Literature DB >> 28422764

3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs.

Ranu Surolia, Fu Jun Li, Zheng Wang, Huashi Li, Gang Liu, Yong Zhou, Tracy Luckhardt, Sejong Bae, Rui-Ming Liu, Sunad Rangarajan, Joao de Andrade, Victor J Thannickal, Veena B Antony.   

Abstract

Year:  2017        PMID： 28422764      PMCID： PMC5396517          DOI： 10.1172/jci.insight.94088

Source DB:  PubMed          Journal:  JCI Insight        ISSN： 2379-3708


× No keyword cloud information.
  4 in total

Review 1.  3D In Vitro Models: Novel Insights into Idiopathic Pulmonary Fibrosis Pathophysiology and Drug Screening.

Authors:  Ana Ivonne Vazquez-Armendariz; Margarida Maria Barroso; Elie El Agha; Susanne Herold
Journal:  Cells       Date:  2022-05-02       Impact factor: 7.666

2.  Fibronectin on the Surface of Extracellular Vesicles Mediates Fibroblast Invasion.

Authors:  Diptiman Chanda; Eva Otoupalova; Kenneth P Hough; Morgan L Locy; Karen Bernard; Jessy S Deshane; Ralph D Sanderson; James A Mobley; Victor J Thannickal
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 7.748

Review 3.  General consensus on multimodal functions and validation analysis of perinatal derivatives for regenerative medicine applications.

Authors:  Michela Pozzobon; Stefania D'Agostino; Maria G Roubelakis; Anna Cargnoni; Roberto Gramignoli; Susanne Wolbank; Florelle Gindraux; Sveva Bollini; Halima Kerdjoudj; Mathilde Fenelon; Roberta Di Pietro; Mariangela Basile; Veronika Borutinskaitė; Roberta Piva; Andreina Schoeberlein; Guenther Eissner; Bernd Giebel; Peter Ponsaerts
Journal:  Front Bioeng Biotechnol       Date:  2022-10-03

4.  Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo.

Authors:  Chang Li; Veronika Rezov; Emmi Joensuu; Ville Vartiainen; Mikko Rönty; Miao Yin; Marjukka Myllärniemi; Katri Koli
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.